Impact of Earlier Postpartum Contact on Postpartum Visit Compliance and Maternal Wellbeing Read more about Impact of Earlier Postpartum Contact on Postpartum Visit Compliance and Maternal Wellbeing
Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy Read more about Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy
Comparison of Ventricular Tachycardia Ablation Strategies in Patients With Ischemic Cardiomyopathy Read more about Comparison of Ventricular Tachycardia Ablation Strategies in Patients With Ischemic Cardiomyopathy
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel Read more about A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA) Read more about Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)
2 Dose Neuraxial Morphine for Prevention of PDPH Read more about 2 Dose Neuraxial Morphine for Prevention of PDPH
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation Read more about A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy Read more about Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer Read more about Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2) Read more about Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)